Section Arrow
VIGL.NASDAQ
- Vigil Neuroscience
Quotes are at least 15-min delayed:2025/07/15 13:16 EDT
Regular Hours
Last
 8.075
+0.005 (+0.06%)
Day High 
8.09 
Prev. Close
8.07 
1-M High
8.07 
Volume 
197.98K 
Bid
8.07
Ask
8.08
Day Low
8.065 
Open
8.07 
1-M Low
7.86 
Market Cap 
376.64M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.01 
20-SMA 7.96 
50-SMA 6.3 
52-W High 8.07 
52-W Low 1.312 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.06/-0.84
Enterprise Value
388.55M
Balance Sheet
Book Value Per Share
1.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
KAPAKairos Pharma Ltd.1.1102+0.4251+62.05%-- 
PLRZPolyrizon Ltd0.9155+0.2334+34.22%-- 
NCNANuCana plc0.0494+0.0035+7.63%-- 
CYCCCyclacel Pharmaceuticals Inc17.465+14.155+427.64%0.08PE
PROKProKidney Corp3.525-0.165-4.47%-- 
Quotes are at least 15-min delayed:2025/07/15 13:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.